GlaxoSmithKline Plc
Last updated on 2017-03-21T20:07+0300.
About this image
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|
| Names | Lang | Count |
|---|---|---|
| Glaxosmithkline Plc | EN | 100.00% |
| Type | Entity Name | Count |
|---|---|---|
 | GlaxoSmithKline | 9.72% |
| Inc | 8.12% |
| Pfizer Inc | 6.11% |
| AstraZeneca PLC | 2.91% |
| Novartis | 2.40% |
| Five Forces | 2.10% |
| SA | 2.10% |
| Pharmaceuticals Inc | 1.80% |
| World Health Organization | 1.60% |
| Teva Pharmaceuticals | 1.50% |
| Reuters Group | 1.30% |
| European Union | 1.20% |
| Roche Holding AG | 1.20% |
| Eli Lilly | 1.20% |
| Drug Administration | 1.10% |
| Abbott Laboratories | 1.10% |
 | Donald Trump | 1.00% |
| Boehringer Ingelheim | 0.90% |
| Bristol Myers Squibb | 0.80% |
| Oxford University | 0.80% |
| Laura Wood | 0.70% |
| British | 0.70% |
| Roche Ltd | 0.60% |
| S government | 0.60% |
| Health Ministry | 0.60% |
| Boris Johnson | 0.60% |
| Amy Rose | 0.60% |
| Dow Jones Newswires | 0.60% |
| Dow Jones | 0.60% |
| Budget Office | 0.60% |
| Type | Entity Name | Score |
|---|---|---|
| GlaxoSmithKline | 0.0499 |
| AstraZeneca PLC | 0.0283 |
| Novartis | 0.023 |
| Five Forces | 0.021 |
| Pharmaceuticals Inc | 0.016 |
| Teva Pharmaceuticals | 0.015 |
| SA | 0.0139 |
| Inc | 0.0121 |
| Roche Holding AG | 0.0119 |
| Eli Lilly | 0.0115 |
| Abbott Laboratories | 0.0101 |
| Boehringer Ingelheim | 0.0089 |
| Pfizer Inc | 0.008 |
| Bristol Myers Squibb | 0.0077 |
| Laura Wood | 0.007 |
| Roche Ltd | 0.006 |
| Pvt Ltd | 0.0058 |
| Miriam Garcia Ferrer | 0.0056 |
| Amy Rose | 0.0055 |
| Bone Health | 0.0055 |
| Dow Jones Newswires | 0.0054 |
| Table | 0.0053 |
| Drug Administration | 0.0051 |
| Budget Office | 0.005 |
| Nadhim Zahawi | 0.005 |
| Youli Edelstein | 0.0049 |
| Congressional Budget Office | 0.0048 |
| Jacinda Ardern | 0.0042 |
| Laboratories Ltd | 0.0041 |
| Oxford University | 0.004 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Thursday, March 4, 2021
3:16:00 AM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 